Am J Perinatol 2012; 29(02): 79-86
DOI: 10.1055/s-0031-1295646
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Predictors of Successful Discontinuation of Supplemental Oxygen in Very Low-Birth-Weight Infants with Bronchopulmonary Dysplasia Approaching Neonatal Intensive Care Unit Discharge

Jennifer M. Trzaski
1   Division of Neonatology, Connecticut Children’s Medical Center, Hartford;
2   Department of Pediatrics, University of Connecticut School of Medicine;
3   Division of Neonatology, University of Connecticut Health Center, Farmington, Connecticut.
,
James I. Hagadorn
1   Division of Neonatology, Connecticut Children’s Medical Center, Hartford;
2   Department of Pediatrics, University of Connecticut School of Medicine;
3   Division of Neonatology, University of Connecticut Health Center, Farmington, Connecticut.
,
Naveed Hussain
1   Division of Neonatology, Connecticut Children’s Medical Center, Hartford;
2   Department of Pediatrics, University of Connecticut School of Medicine;
3   Division of Neonatology, University of Connecticut Health Center, Farmington, Connecticut.
,
Janet Schwenn
3   Division of Neonatology, University of Connecticut Health Center, Farmington, Connecticut.
,
Claudia Wittenzellner
3   Division of Neonatology, University of Connecticut Health Center, Farmington, Connecticut.
› Author Affiliations
Further Information

Publication History

09 February 2011

07 July 2011

Publication Date:
30 November 2011 (online)

Abstract

We sought to identify factors associated with readiness to discontinue supplemental oxygen and to gain weight in very low-birth-weight (VLBW) infants with bronchopulmonary dysplasia (BPD) approaching neonatal intensive care unit (NICU) discharge. From 2004 to 2009, VLBW infants ≥34 weeks’ postmenstrual age (PMA) on nasal cannula supplemental oxygen were challenged with room air at rest, during activity, and feeding as routine care. Outcome and clinical data were collected retrospectively. Challenges were divided into derivation and validation cohorts. We performed comparative and hierarchical logistic regression analyses, constructing a predictive model with passed challenge as outcome. Of 233 infants (birth weight 901 ± 245 g, gestational age 266/ 7 ± 2 weeks), 988 had challenges at 382/ 7 ± 3 weeks’ PMA. Weight gain was 12.4 ± 5 g/kg/d in the week following passed challenges and 11.2 ± 5.3 g/kg/d following failed challenges (p = 0.08). Increasing weight at time of challenge was associated with increased adjusted odds of passing. Increasing capillary pco 2, cannula flow rate, pulmonary acuity score, and history of patent ductus arteriosus (PDA) ligation decreased odds of passing. Receiver operating characteristic curve area was 0.82 in the validation cohort. The model performed well within pco 2 and pulmonary acuity score subgroups. Weight, pco 2, cannula flow rate, pulmonary acuity score, and history of PDA ligation identify infants with BPD ready to maintain saturation and gain weight without supplemental oxygen.

 
  • References

  • 1 Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723-1729
  • 2 Bhandari A, Bhandari V. Pitfalls, problems, and progress in bronchopulmonary dysplasia. Pediatrics 2009; 123: 1562-1573
  • 3 Groothuis JR, Rosenberg AA. Home oxygen promotes weight gain in infants with bronchopulmonary dysplasia. Am J Dis Child 1987; 141: 992-995
  • 4 Allen J, Zwerdling R, Ehrenkranz R , et al; American Thoracic Society. Statement on the care of the child with chronic lung disease of infancy and childhood. Am J Respir Crit Care Med 2003; 168: 356-396
  • 5 Askie LM, Henderson-Smart DJ, Irwig L, Simpson JM. Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med 2003; 349: 959-967
  • 6 The STOP-ROP Multicenter Study Group. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics 2000; 105: 295-310
  • 7 Jobe AH, Ikegami M. Prevention of bronchopulmonary dysplasia. Curr Opin Pediatr 2001; 13: 124-129
  • 8 Walsh MC, Wilson-Costello D, Zadell A, Newman N, Fanaroff A. Safety, reliability, and validity of a physiologic definition of bronchopulmonary dysplasia. J Perinatol 2003; 23: 451-456
  • 9 Walsh MC, Yao Q, Gettner P , et al; National Institute of Child Health and Human Development Neonatal Research Network. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics 2004; 114: 1305-1311
  • 10 Patel AL, Engstrom JL, Meier PP, Jegier BJ, Kimura RE. Calculating postnatal growth velocity in very low birth weight (VLBW) premature infants. J Perinatol 2009; 29: 618-622
  • 11 Patel AL, Engstrom JL, Meier PP, Kimura RE. Accuracy of methods for calculating postnatal growth velocity for extremely low birth weight infants. Pediatrics 2005; 116: 1466-1473
  • 12 Madan A, Brozanski BS, Cole CH, Oden NL, Cohen G, Phelps DL. A pulmonary score for assessing the severity of neonatal chronic lung disease. Pediatrics 2005; 115: e450-e457
  • 13 Ambalavanan N, Van Meurs KP, Perritt R , et al; NICHD Neonatal Research Network, Bethesda, MD. Predictors of death or bronchopulmonary dysplasia in preterm infants with respiratory failure. J Perinatol 2008; 28: 420-426
  • 14 Sinkin RA, Cox C, Phelps DL. Predicting risk for bronchopulmonary dysplasia: selection criteria for clinical trials. Pediatrics 1990; 86: 728-736